Controlled study compares smPCNL and ESWL in pediatric patients, suggesting smPCNL for better outcomes.
ESWL remains the preferred first-line option for many pediatric patients due to its safety and non-invasive nature. However, smPCNL provides higher single-session stone-free rates for 10-20 mm renal stones and may reduce repeated anesthesia exposure. SmPCNL should be considered a viable first-line alternative to achieve higher stone-free rates without increasing complication risk. Prospective, multicenter randomized trials are warranted.
No takes yet. Share an insight, caveat, or question.
Sevim et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: